Launching a drug development company with novel technology from academia
Our corporate group has worked with hundreds of entrepreneurs at this stage to help them optimally and efficiently select and form the appropriate legal entity
We have worked with over 2000 companies, investors and research institutions.
All clients, by client group
- Alliance Foundation Trials, LLC
- Bluefield Project to Cure FTD
- Cure GM1 Foundation
- FB2 Services (Florida Biologix)
- Global Alliance for TB Drug Development
- Ibis Reproductive Health
- Massachusetts Eye and Ear
- Open Philanthropy LLC
- Partners In Health
- The Center for Discovery
- AB Biosciences, Inc.
- Ambulomics, Inc.
- Arcaea, LLC
- Articulate Labs, Inc.
- Bitome, Inc.
- Covid Rapid AB Test, LLC
- Covid Rapid Test - Texas, LLC
- Custom Automated Prosthetics
- Day Zero Diagnostics, Inc.
- Dialco Medical Inc.
- Digital Cognition Technologies, Inc.
- Digital Cognition Technologies, Inc.
- Discovery Life Sciences, LLC
- GelMEDIX, Inc.
- hearX Group (Pty) Ltd.
- HighRes Biosolutions, Inc.
- Instylla, Inc.
- Occlutech International AB
- Omada Health, Inc.
- Palette Life Sciences AB
- PhosImmune
- Presympto, Inc.
- Savran Technologies Inc.
- Sirtex Technology Pty Ltd
- Spectral Medical Inc.
- Techcomp (Holdings) Limited
- Tides Medical LLC
- Vizgen, Inc.
- Abata Therapeutics, Inc.
- Actithera, Inc.
- Adrenas Therapeutics, Inc.
- AesRx
- Affini-T Therapeutics, Inc.
- Affinia Therapeutics, Inc.
- Affinivax, Inc.
- Agenus, Inc.
- Akouos, Inc.
- Aldeyra Therapeutics, Inc.
- Aliada Therapeutics, Inc.
- Allorion Therapeutics Inc.
- Allyx Therapeutics, Inc.
- Alpheus Medical, Inc.
- Altum Pharmaceuticals Inc.
- AmbAgon Therapeutics, Inc.
- Ananda Scientific, Inc.
- Anebulo Pharmaceuticals, Inc.
- Annapurna Therapeutics
- Anokion US, Inc.
- Anthos Therapeutics, Inc.
- AnTolRx, Inc.
- Apic Bio, Inc.
- Arbor Biotechnologies, Inc.
- ARKUDA Therapeutics, Inc.
- Arrakis Therapeutics, Inc.
- Arsanis Therapeutics
- Artax Biopharma, Inc.
- Artivus Therapeutics, Inc.
- AS2 Bio, LLC
- Ascendant Biotech Corporation
- AsclepiX Therapeutics, Inc.
- Aspa Therapeutics, Inc.
- Astria Therapeutics, Inc.
- Atara Biotherapeutics
- Atavistik Bio
- aTyr Pharma, Inc.
- Aura Biosciences, Inc.
- Auron Therapeutics, Inc.
- Auxolytic, Ltd.
- AvenCell Therapeutics, Inc.
- Avenge Bio, Inc.
- Axial Therapeutics, Inc.
- Beam Therapeutics, Inc.
- BeiGene, Ltd.
- Bicara Therapeutics Inc.
- BIORCHESTRA Co., Ltd.
- BioSynapse, Inc.
- Black Diamond Therapeutics, Inc.
- Blue Oak Pharmaceuticals, Inc.
- Bridge Biotherapeutics Inc.
- BridgeBio Pharma
- Carbon Biosciences, Inc.
- Catamaran Bio, Inc.
- Cedilla Therapeutics, Inc.
- CG Pharmaceuticals, Inc.
- Chinook Therapeutics, Inc.
- Cimeio Therapeutics AG
- Claris Biotherapeutics, Inc.
- Clear Creek Bio, Inc.
- Clover Key Bioscience, Inc.
- Cogent Biosciences, Inc.
- Cora Biosciences, Inc.
- Corbus Pharmaceuticals Inc.
- Corner Therapeutics, Inc.
- Crimson BioPharm Inc.
- Curie Therapeutics, Inc.
- Curileum Discovery Ltd
- Cybrexa, Inc.
- Cyteir Therapeutics, Inc.
- DEM BioPharma, Inc.
- DermBiont, Inc.
- Dianthus Therapeutics, Inc.
- Diceros Therapeutics, Inc.
- Dyne Therapeutics, Inc.
- Editas Medicine, Inc.
- Eicosis LLC
- Elevian, Inc.
- Elicio Therapeutics, Inc.
- Emugen Therapeutics, Inc.
- Enzyme By Design, Inc.
- Epalex Corporation
- Epibiologics, Inc.
- EpimAb Biotherapeutics Inc.
- Ernest Pharmaceuticals, LLC
- Eumentis Therapeutics, Inc.
- EvolveImmune Therapeutics, Inc.
- Expansion Therapeutics, Inc.
- F-star Delta Limited
- Finch Therapeutics, Inc.
- Flame Biosciences, Inc.
- Flare Therapeutics
- FOG Pharmaceuticals, Inc.
- Forma Therapeutics, Inc.
- Fulcrum Therapeutics, Inc.
- Fusion Pharmaceuticals, Inc.
- General Oncology, Inc.
- Generate Biomedicines
- GV.M1 Inc.
- GV20 Therapeutics LLC
- H3 Biomedicine
- Hatch Therapeutics, Inc.
- hC Bioscience, Inc.
- HilleVax, Inc
- Holobiome, Inc.
- HotSpot Therapeutics, Inc.
- Huya Bioscience International, LLC
- IDBiologics, Inc.
- IDEAYA Biosciences, Inc.
- Ikena Oncology, Inc.
- Imara, Inc.
- ImmunoGen, Inc.
- Infinity Pharmaceuticals, Inc.
- InflaRx GmbH
- Inozyme Pharma Inc.
- INSTA Therapeutics, Inc.
- Intellia Therapeutics, Inc.
- Intergalactic Therapeutics, Inc
- iOmx Therapeutics AG
- Ipsen Bioscience Inc.
- iTeos Therapeutics, Inc.
- Jounce Therapeutics, Inc.
- KalVista Pharmaceuticals, Inc.
- Kantum Pharma, Inc.
- Kanyos Bio, Inc.
- Keros Therapeutics, Inc.
- Kezar Life Sciences, Inc.
- Kirilys Therapeutics, Inc.
- Kite Pharma, Inc.
- Kojin Therapeutics, Inc.
- KSQ Therapeutics, Inc.
- Kymera Therapeutics, Inc.
- Laronde
- Lexeo Therapeutics, Inc.
- Lyra Therapeutics, Inc.
- Lysosomal Therapeutics, Inc.
- Magnet Biomedicine, Inc.
- MarPam Pharma, LLC
- Matchpoint Therapeutics, Inc.
- MediBeacon Inc.
- Merlin Therapeutics, Inc.
- Mnemo Therapeutics SAS
- Molecular Skin Therapeutics, Inc.
- Molecular Templates, Inc.
- Moment Bio, Inc.
- MorphoSys AG
- Myeloid Therapeutics, Inc.
- Mythic Therapeutics, Inc.
- Neomorph, Inc.
- Neurogastrx, Inc.
- NextPoint Therapeutics, Inc.
- NiKang Therapeutics, Inc.
- Nocion Therapeutics, Inc.
- Normunity AccelCo, Inc.
- Normunity, Inc.
- Nurix Therapeutics, Inc.
- Obsidian Therapeutics, Inc.
- Okava Pharmaceuticals, Inc.
- Olaris Inc.
- Oligomerix, Inc.
- Omega Therapeutics, Inc.
- Oncorus, Inc.
- ONK Therapeutics Limited
- Orna Therapeutics, Inc.
- Ossianix, Inc.
- Otter Immuno-oncology, LLC
- PanOptica, Inc.
- Paragon Therapeutics, Inc.
- Paratus Sciences Corporation
- Parthenon Therapeutics, Inc.
- Pathalys Pharma, Inc.
- Peptilogics, Inc.
- perForm biologics, inc.
- Phenex Pharmaceuticals AG
- Phoenix Tissue Repair, Inc.
- Photys, Inc.
- Phylaxis Bioscience, LLC
- PIC Therapeutics, Inc.
- Pinetree Therapeutics, Inc.
- Polymed Biopharmaceuticals, Inc.
- Promedior, Inc.
- ProThera Biologics, Inc.
- Pyxis Oncology, Inc.
- Q1, Inc.
- QurAlis Corporation
- QurAlis Corporation
- Regenacy Pharmaceuticals, Inc.
- Rekindle Therapeutics Inc.
- Relay Therapeutics, Inc.
- Repare Therapeutics, Inc.
- resTORbio, Inc.
- Revalia Bio, Inc.
- Rheos Medicines, Inc.
- Rhoshan Pharmaceuticals, Inc.
- Ridgeline Discovery GmbH
- Right Brain Bio, Inc.
- Rila Therapeutics, Inc.
- Rizana Therapeutics, Inc.
- Rubius Therapeutics, Inc.
- SalioGen Therapeutics, Inc.
- Schrödinger, Inc.
- Scorpion Therapeutics, Inc.
- Seal Rock Therapeutics, Inc.
- Sentien Biotechnologies, Inc.
- Shenzhen Pharmacin Co., Ltd.
- Sieben Therapeutics, Inc.
- Simcha IL-18, Inc.
- Sionna Therapeutics, Inc.
- SNIPR BIOME ApS
- Sojournix, Inc.
- SonALAsense, Inc.
- Sonnet BioTherapeutics, Inc.
- Sorrento Therapeutics, Inc.
- SOTIO Biotech Inc.
- Souffle Therapeutics
- Spruce Biosciences, Inc.
- STORM Therapeutics Ltd.
- Strand Therapeutics, Inc.
- Summation Bio, Inc.
- Surface Oncology, Inc.
- SURGE Therapeutics, Inc.
- Syndax Pharmaceuticals, Inc.
- Synedgen, Inc.
- Syros Pharmaceuticals, Inc.
- T-knife Therapeutics, Inc.
- Tasca Therapeutics Corp.
- Tavanta Therapeutics, Inc.
- Tectonic Therapeutic, Inc.
- Teneobio, Inc.
- Tessera Therapeutics, Inc.
- Test 6
- Theaprin Pharmaceuticals, Inc.
- Theragnostics Ltd.
- Third Harmonic Bio, Inc.
- Totus Medicines Inc.
- TransformaTX Biotherapeutics LLC
- Transition Bio, Inc.
- Treadwell Therapeutics, Inc.
- Triplet Therapeutics, Inc.
- Vedere Bio, Inc.
- Vernal Biosciences, Inc.
- Verra Therapeutics, LLC
- Versatope Therapeutics, Inc.
- Verseau Therapeutics, Inc.
- Vertex Pharmaceuticals Incorporated
- Vertical Bio AG
- Verve Therapeutics, Inc.
- Viridian Therapeutics, Inc.
- Viridian, LLC
- Volastra Therapeutics, Inc.
- Wade Biomedicines Inc.
- Walking Fish Therapeutics, Inc.
- WAVE Life Sciences Ltd.
- Xbiome, Inc.
- Xellar, Inc.
- XenImmune Therapeutics, Inc.
- Yumanity Therapeutics
- Yumanity Therapeutics
- Zenon Biotech, Inc.
- 143 Digital, LLC
- Advanced Development Methods, Inc.
- Artha Networks, Inc.
- Codiscope, LLC
- Curated Planet, LLC
- Dexai Robotics, Inc
- Drishti Technologies, Inc.
- Gleason Technology, Inc.
- GlobalSign, Inc.
- IQ Proteomics, LLC
- Liteboxer Technologies, Inc.
- Mel Robbins Productions, Inc.
- Muzooka, Inc.
- Optera Life Sciences, LLC
- Sibyl Analytics, LLC
- YBRP, Inc.
- Zone Motion, LLC
- .406 Ventures
- 4D Molecular Therapeutics, Inc.
- 5AM Venture Management LLC
- 6 Dimensions Capital
- AllerFund Ventures, LLC
- Arch Venture Fund XII
- Atlas Venture
- CBT Advisors
- CoVenture
- Cure Ventures Management, L.P.
- Epidarex Management, Ltd.
- Flagship Pioneering
- GG1978 SICAF SIF
- Gimv NV
- GISEV EH LLC
- GV Management Company, LLC
- Hutchison MediPharma Limited
- Lundbeckfond Ventures
- Novo Ventures
- Ross Equity Partners, L.P.
- Sann Opportunity Zone, LLC
- Soffer Holdings LLC
- Test 3
- Test 4
- Test 5
- Test Client 2
- U.S. Equity Holdings, LLC
- Versant Ventures Management, LLC
Recent transactions
6 Dimensions Capital
VC InvestmentsEquity investments in multiple portfolio companies, including Hibercell
Website
Puma Biotechnology, Inc.
Clinical TrialCRO and Site Agreements for an Open-Label, Phase 2 Study with 30 Sites in 9 Countries exploring the efficiency of Neratinib on Patients with Solid Tumors with Somatic Human Epidermal Growth Factor Receptor (EGFR, HER2, HER3) Mutations Or EGFR Gene Amplification
See Study
Vizgen, Inc.
Series C FinancingVizgen raises Series C equity funding led by Blue Water Life Science Advisors, LLC, ARCH Venture Fund X, L.P. and other existing investors
Press Release
Vernal Biosciences, Inc.
Series A FinancingVernal Biosciences raises $21M Series A equity funding led by Dynamk Life Sciences Fund, L.P., Charles River Laboratories, Inc. and Ampersand 2020 Limited Partnership
Press Release
Artax Biopharma, Inc. + Advent Life Sciences Fund II LP
Series B Financing (Series B4)Artax Biopharma raises Series B-4 round of equity funding led by Advent Life Sciences Fund II LP, Advent Life Sciences LLP, Columbus Life Science Fund II, FCR, Hiyuli Ventures Limited, Belinda A. Termeer, and other existing investors, plus new investors including Sound Bioventures Fund I AB and and Eli Lilly
Press Release
Dianthus Therapeutics, Inc.
Series A FinancingDianthis raises $100 million Series A financing led by 5AM Ventures, Fidelity Management & Research Company, Avidity Partners, Venrock, Fairmount Funds, Tellus BioVentures and other investors
Press Release
Summation Bio, Inc.
Series A FinancingSummation Bio raises Series A equity funding led by RA Capital Healthcare Fund, L.P., RA Capital NEXUS Fund, L.P., RA Capital NEXUS Fund III, L.P., Blackwell Partners LLC and other existing investors
ONK Therapeutics Limited + Intellia Therapeutics, Inc.
License, Collaboration and Option AgreementLicense, Collaboration and Option Agreement to advance allogeneic CRISPR-Edited NK cell therapies, with milestones up to $920M per product plus royalties
Press Release
DermBiont, Inc. + Chromaderm, Inc.
Private Company AcquisitionDermBiont acquires Chromaderm, Inc.
Press Release
Sirtex Technology Pty Ltd
Clinical TrialCRO and Site Agreements for a pivotal device study with 15 US sites to evaluate the safety and effectiveness of SIRT using SIR-Spheres Y-90 resin microspheres as first-line treatment for local control of HCC (Barcelona clinic liver cancer (BCLC) stage A, BCLC stage B1 and BCLC stage B2)
See Study
IDEAYA Biosciences, Inc.
Clinical TrialCRO and Site Agreements for a Phase I Study to evaluate the safety, pharmacokinetics, and pharmacodynamics of escalating doses of IDE397 (MAT2A inhibitor) in patients with advanced solid tumors
See Study
Vizgen, Inc.
Series B FinancingVizgen raises Series B equity funding from Northpond Ventures LP, ARCH Venture Fund X, L.P., Novalis LifeSciences LLC, Tao Capital Management, Pura Vida Investments and other current investors
Press Release